American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of common stock in IBEX Limited as of September 30, 2026.
Key Highlights
- Three reporting persons: American Century Investment Management, Inc. (investment adviser), American Century Companies, Inc. (holding company), and Stowers Institute for Medical Research (holding company) each reported the same aggregate position.
- Shares beneficially owned: Each reporting person disclosed 673,212 shares of IBEX Limited common stock.
- Percent of class: The 673,212 shares represent 5.1% of the outstanding class, according to the filing.
- Sole voting and dispositive power: All 673,212 shares are attributed to sole voting power and sole dispositive power, with 0 shares held under shared voting or shared dispositive power.
- Event date: The date of the event requiring this filing is stated as September 30, 2026.
- Ordinary course certification: The filing certifies the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
American Century's Joint 13G Filing on IBEX Limited Common Stock
According to the Schedule 13G filed on November 16, 2026, three affiliated entities jointly reported a beneficial ownership position in IBEX Limited (NASDAQ:IBEX), a company whose principal executive offices are located at 1717 Pennsylvania Avenue NW, Suite 825, Washington, District of Columbia, 20006. The triggering event date is listed as September 30, 2026, and all three filers share the same Kansas City, Missouri address at 4500 Main Street, 9th Floor.
The filing identifies American Century Investment Management, Inc. ("ACIM") as an investment adviser and a wholly-owned subsidiary of American Century Companies, Inc. ("ACC"). ACC, in turn, is controlled by Stowers Institute for Medical Research. Each of the three entities reported beneficial ownership of 673,212 shares, representing 5.1% of the class. The filing notes that "various persons, including the investment companies and separate institutional investor accounts" that ACIM serves as investment adviser have the right to receive dividends from or proceeds from the sale of the subject securities, and that no single client advised by ACIM owns more than 5% of the class.
The joint filing was signed by John Pak, Senior Vice President, on behalf of both ACIM and ACC, and by Joselyn Verschelden, Authorized Signer, on behalf of Stowers Institute for Medical Research, each dated November 16, 2026. ACIM is described as "an investment adviser registered under Section 203 of the Investment Advisers Act of 1940."
What Was Disclosed
Three affiliated entities filed a joint Schedule 13G disclosing aggregate beneficial ownership of 673,212 shares, or 5.1%, of IBEX Limited common stock, with all shares held under sole voting and dispositive power as of September 30, 2026.




Please wait processing your request...